In this CIO.Inc feature, Alister Campbell, vice president of global science and technology at Dotmatics discusses how traditionally, science has moved faster than software, but artificial intelligence might be closing the gap.
The piece highlights that the historical challenge has been the "last mile" problem—transitioning a model from a data scientist's notebook to a integrated, scalable, and reliable application. This gap often caused delays, failures, and wasted resources.
Dotmatics is leading this race to AI—empowering scientists with tools that act like “a thousand lab researchers at their side.” The result: faster, more cost-effective development of life-saving therapeutics, and a future where patients gain access to safer, more personalized medicines in years instead of decades.
Watch the full interview to hear Dotmatics perspective on how AI is reshaping the future of medicine.
Learn More About Dotmatics
Schedule a meeting with our team to learn more about Luma's AI capabilities.